One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...

In this issue, C&EN takes a look at how the pandemic changed science and scientists and how science will continue to work to ...

Amid one of the largest measles outbreaks in the United States in nearly a decade, anti-vaccine activists are promoting false ...

Estimates of current mid-season flu vaccine effectiveness (VE) in Europe and China range from 32% to 58% overall, with ...

Gut microbiota may be the key factor explaining why certain individuals do not respond well to the pneumococcal vaccine-a bacterium that can cause various diseases, such as pneumonia.